Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Bell

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Psychiatry Research|December 1, 1990
Seasonal changes in cyanoimipramine specific platelet 3H-imipramine binding in depressionE M DeMet, K M Bell, C Reist, et al.
International Journal of Cancer|October 23, 1997
Vascular response of tumour and normal tissues to endothelin-1 following antagonism of ET(A) and ET(B) receptors in anaesthetised ratsK M Bell, V E Prise, D J Chaplin, et al.
International Journal of Cancer|September 4, 1996
A comparative study of tumour blood flow modification in two rat tumour systems using endothelin-1 and angiotensin II: influence of tumour size on angiotensin II responseK M Bell, V E Prise, K M Shaffi, et al.
Human Genetics|May 8, 2000
SOX14 is a candidate gene for limb defects associated with BPES and Möbius syndromeH P Wilmore, M J Smith, S A Wilcox, et al.
International Journal of Cancer|February 6, 1999
Modification of blood flow in the HSN tumour and normal tissues of the rat by the endothelin ET(B) receptor agonist, IRL 1620K M Bell, D J Chaplin, B A Poole, et al.
British Journal of Cancer|June 23, 2005
The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modificationM Cemazar, I Wilson, V E Prise, et al.
Biological Psychiatry|September 1, 1989
Changes in platelet 3H-imipramine binding with chronic imipramine treatment are not state-dependentE M DeMet, R H Gerner, K M Bell, et al.
Human Mutation|April 29, 1998
Familial Kallmann syndrome: a novel splice acceptor mutation in the KAL geneM J O'Neill, B Tridjaja, M J Smith, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|September 1, 2015
In vitro evaluation of translating and rotating plates using a robot testing system under follower loadY Yan, K M Bell, R A Hartman, et al.
British Journal of Cancer|December 1, 1996
Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: significance for blood flow modificationG M Tozer, V E Prise, K M Bell, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Psychiatry Research|December 1, 1990
Seasonal changes in cyanoimipramine specific platelet 3H-imipramine binding in depressionE M DeMet, K M Bell, C Reist, et al.
International Journal of Cancer|October 23, 1997
Vascular response of tumour and normal tissues to endothelin-1 following antagonism of ET(A) and ET(B) receptors in anaesthetised ratsK M Bell, V E Prise, D J Chaplin, et al.
International Journal of Cancer|September 4, 1996
A comparative study of tumour blood flow modification in two rat tumour systems using endothelin-1 and angiotensin II: influence of tumour size on angiotensin II responseK M Bell, V E Prise, K M Shaffi, et al.
Human Genetics|May 8, 2000
SOX14 is a candidate gene for limb defects associated with BPES and Möbius syndromeH P Wilmore, M J Smith, S A Wilcox, et al.
International Journal of Cancer|February 6, 1999
Modification of blood flow in the HSN tumour and normal tissues of the rat by the endothelin ET(B) receptor agonist, IRL 1620K M Bell, D J Chaplin, B A Poole, et al.
British Journal of Cancer|June 23, 2005
The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modificationM Cemazar, I Wilson, V E Prise, et al.
Biological Psychiatry|September 1, 1989
Changes in platelet 3H-imipramine binding with chronic imipramine treatment are not state-dependentE M DeMet, R H Gerner, K M Bell, et al.
Human Mutation|April 29, 1998
Familial Kallmann syndrome: a novel splice acceptor mutation in the KAL geneM J O'Neill, B Tridjaja, M J Smith, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|September 1, 2015
In vitro evaluation of translating and rotating plates using a robot testing system under follower loadY Yan, K M Bell, R A Hartman, et al.
British Journal of Cancer|December 1, 1996
Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: significance for blood flow modificationG M Tozer, V E Prise, K M Bell, et al.
Pageof 5